|
MX339524B
(es)
*
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
US7351413B2
(en)
*
|
2002-02-21 |
2008-04-01 |
Lorantis, Limited |
Stabilized HBc chimer particles as immunogens for chronic hepatitis
|
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
EP2351579B1
(en)
*
|
2002-10-11 |
2016-09-21 |
Novartis Vaccines and Diagnostics S.r.l. |
Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages
|
|
GB0227346D0
(en)
*
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
CA2509484C
(en)
*
|
2002-12-10 |
2012-03-20 |
Lorantis Ltd. |
Stabilized immunogenic hbc chimer particles
|
|
DK1587537T3
(da)
*
|
2003-01-30 |
2012-07-16 |
Novartis Ag |
Injicerbare vacciner mod multiple meningococ-serogrupper
|
|
ES2397923T3
(es)
*
|
2003-10-02 |
2013-03-12 |
Novartis Ag |
Vacunas líquidas para múltiples serogrupos meningocócicos
|
|
GB0408977D0
(en)
*
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
GB2414667A
(en)
*
|
2004-06-03 |
2005-12-07 |
Isis Innovation |
Vaccine compositions of N. meningitidis PorA and FetA antigens
|
|
DE602005025647D1
(de)
*
|
2004-07-23 |
2011-02-10 |
Novartis Vaccines & Diagnostic |
Polypeptide für die oligomerisierung von antigenen
|
|
GB0419408D0
(en)
*
|
2004-09-01 |
2004-10-06 |
Chiron Srl |
741 chimeric polypeptides
|
|
CN101107007B
(zh)
*
|
2005-01-27 |
2011-08-17 |
奥克兰儿童医院及研究中心 |
对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗
|
|
GB0524066D0
(en)
*
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
EP1925318A1
(en)
*
|
2006-11-20 |
2008-05-28 |
Paul-Ehrlich-Institut |
Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu
|
|
AU2009215364B2
(en)
*
|
2008-02-21 |
2014-09-18 |
Glaxosmithkline Biologicals S.A. |
Meningococcal fHBP polypeptides
|
|
AU2009223613B2
(en)
*
|
2008-03-10 |
2014-09-25 |
Children's Hospital & Research Center At Oakland |
Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
|
|
MX2010012999A
(es)
*
|
2008-05-30 |
2012-03-07 |
U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army |
Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
|
|
EP2294085A1
(en)
*
|
2008-06-09 |
2011-03-16 |
Novartis AG |
Antibodies against neisserial factor h binding protein
|
|
WO2010028096A2
(en)
*
|
2008-09-03 |
2010-03-11 |
Children's Hospital & Research Center At Oakland |
Peptides presenting an epitope of an a domain of factor h binding protein and methods of use
|
|
GB0819633D0
(en)
*
|
2008-10-25 |
2008-12-03 |
Isis Innovation |
Composition
|
|
CN104548082A
(zh)
*
|
2009-03-24 |
2015-04-29 |
诺华股份有限公司 |
为脑膜炎球菌因子h结合蛋白添加佐剂
|
|
US9266942B2
(en)
*
|
2009-04-30 |
2016-02-23 |
Children's Hospital & Research Center Oakland |
Chimeric factor H binding proteins (fHbp) and methods of use
|
|
WO2011024072A2
(en)
*
|
2009-08-27 |
2011-03-03 |
Novartis Ag |
Hybrid polypeptides including meningococcal fhbp sequences
|
|
CA2779816A1
(en)
*
|
2009-10-27 |
2011-05-05 |
Novartis Ag |
Modified meningococcal fhbp polypeptides
|
|
EP2544714A1
(en)
*
|
2010-03-10 |
2013-01-16 |
GlaxoSmithKline Biologicals S.A. |
Vaccine composition
|
|
TR201802933T4
(tr)
*
|
2010-03-30 |
2018-03-21 |
Childrens Hospital & Res Center At Oakland |
Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi.
|
|
EP2556085A2
(en)
*
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Protease-activatable pore-forming polypeptides
|
|
WO2011161653A1
(en)
*
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
KR101584871B1
(ko)
*
|
2010-09-10 |
2016-01-22 |
와이어쓰 엘엘씨 |
네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체
|
|
GB201015132D0
(en)
|
2010-09-10 |
2010-10-27 |
Univ Bristol |
Vaccine composition
|
|
WO2013078223A1
(en)
*
|
2011-11-23 |
2013-05-30 |
Children's Hospital & Research Center Oakland |
Anti-factor h binding protein antibodies and methods of use thereof
|
|
EP2797624A1
(en)
*
|
2011-12-29 |
2014-11-05 |
Novartis AG |
Adjuvanted combinations of meningococcal factor h binding proteins
|
|
WO2013132040A2
(en)
*
|
2012-03-08 |
2013-09-12 |
Novartis Ag |
In vitro potency assay for protein-based meningococcal vaccines
|
|
SA115360586B1
(ar)
*
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
CA2865745C
(en)
*
|
2012-03-09 |
2018-01-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
ES2847923T3
(es)
*
|
2012-06-14 |
2021-08-04 |
Glaxosmithkline Biologicals Sa |
Vacunas contra el meningococo del serogrupo X
|
|
GB201215005D0
(en)
*
|
2012-08-23 |
2012-10-10 |
Isis Innovation |
Stabilised meningitis vaccine
|
|
CA2903716C
(en)
*
|
2013-03-08 |
2019-04-09 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
US20160030544A1
(en)
*
|
2013-03-14 |
2016-02-04 |
Isis Innovation Limited |
Immunogenic composition to neisseria
|
|
RU2662968C2
(ru)
*
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
|
CN106661092B
(zh)
*
|
2014-02-28 |
2021-07-06 |
葛兰素史密丝克莱恩生物有限公司 |
修饰的脑膜炎球菌fHbp多肽
|
|
BR112017001417B1
(pt)
*
|
2014-07-23 |
2023-11-07 |
Children's Hospital & Research Center At Oakland |
Variantes da proteína de ligação ao fator h (fhbp), composição imunogênica e uso de uma fhbp variante referência cruzada
|
|
EP3223847A1
(en)
|
2014-11-28 |
2017-10-04 |
Janssen Vaccines & Prevention B.V. |
Meningitis b vaccine
|
|
KR20190049940A
(ko)
*
|
2015-02-19 |
2019-05-09 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
|
GB201614687D0
(en)
*
|
2016-08-31 |
2016-10-12 |
Univ Oxford Innovation Ltd |
fHbp scaffold
|
|
SG11201906519RA
(en)
*
|
2017-01-31 |
2019-08-27 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|